Ingevity reported Q3 2020 net sales of $332 million, a decrease of 7.8% compared to the prior year quarter. Net income increased by 16.7% to $70 million, and adjusted EBITDA rose by 11.9% to $128 million. The company also generated $74 million in free cash flow and increased its full-year adjusted EBITDA guidance to $355 million - $365 million and sales guidance to $1.15 billion - $1.20 billion.
Net sales were $332 million, down 7.8% year-over-year due to COVID-19 impacts.
Net income increased 16.7% year-over-year to $70 million, with a net income margin of 21.1%.
Adjusted EBITDA increased 11.9% year-over-year to $128 million, with an adjusted EBITDA margin of 38.5%.
The company generated $74 million in free cash flow.
Ingevity narrowed its fiscal year 2020 guidance for sales from between $1.10 billion and $1.20 billion to between $1.15 billion and $1.20 billion, and increased and narrowed its guidance for adjusted EBITDA from between $310 million and $350 million to between $355 million and $365 million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance